BFEC
TMDI

Benjamin F. Edwards & Company’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40
Closed – – 1926
2019
Q4 		$0 Hold
40
– – ﹤0.01% 1968
2019
Q3 		$0 Hold
40
– – ﹤0.01% 2007
2019
Q2 		$0 Hold
40
– – ﹤0.01% 1991
2019
Q1 		$0 Sell
40
-23
-37% -$75 ﹤0.01% 1794
2018
Q4 		$0 Hold
63
– – ﹤0.01% 1787
2018
Q3 		$0 Hold
63
– – ﹤0.01% 1673
2018
Q2 		$0 Buy
+63
New +$379 ﹤0.01% 1669

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Benjamin F. Edwards & Company's TMDI Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2020, closing a stake of 40 shares.

Benjamin F. Edwards & Company first reported a position in TMDI in Q2 2018 and held it in 7 quarters. The position peaked at $0 in Q4 2019. 39 funds tracked by Wall St. Rank hold TMDI as of Q1 2020.

  • Benjamin F. Edwards & Company reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 40 Titan Medical Inc. Ordinary Shares shares in Q1 2020.
  • Benjamin F. Edwards & Company first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and held it in 7 quarters.
  • Benjamin F. Edwards & Company's Titan Medical Inc. Ordinary Shares position peaked at $0 in Q4 2019.
  • 39 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.